Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OIP5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TGFB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MARCKS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CALM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS33A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM171A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYBRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SIKE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP1B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on